- Home
- CYH vs OCGN Comparison
CYH vs OCGN Comparison
Compare CYH & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYH | OCGN |
|---|---|---|
| Founded | 1985 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.5M | 387.3M |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | CYH | OCGN |
|---|---|---|
| Price | $3.23 | $1.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $3.73 | ★ $7.00 |
| AVG Volume (30 Days) | 2.0M | ★ 3.1M |
| Earning Date | 10-23-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $12,644,000,000.00 | $5,370,000.00 |
| Revenue This Year | $0.04 | $32.40 |
| Revenue Next Year | $0.86 | N/A |
| P/E Ratio | $1.31 | ★ N/A |
| Revenue Growth | 0.74 | ★ 14.26 |
| 52 Week Low | $2.24 | $0.52 |
| 52 Week High | $4.47 | $1.90 |
Technical Indicators
Market Signals| Indicator | CYH | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.02 | 59.94 |
| Support Level | $3.26 | $1.18 |
| Resistance Level | $3.74 | $1.26 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 5.19 | 92.08 |
Price Performance
Historical ComparisonAbout CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").